5 Scientifically Proven Truisms About The Amazing Pharmacological Effects Of Psilocybin

In the realm of contemporary science and healthcare, there exists an increasingly fervent excitement centered around an unassuming fungus that has captivated the imagination of researchers, clinicians, and the curious alike. Psilocybin, the mystical compound found in magic mushrooms, has emerged from the research periphery and stigma to take center stage in the world of medicine and scientific exploration. Last week’s Phase 2 readout by Cybin Inc. (NASDAQ: CYBN) (deuterated psilocybin compound CYB003) was the latest such example of the tremendous critical mass of positive research is accumulating. But it surely won’t be the last. With dozens on clinical and pre-clinical efficacious studies in the books, psilocybin is accruing increasing confidence that it could be a frontline treatment for depression (and, possibly, off-label for co-morbid conditions) in the not-too-distant future. With a resurgence of interest in the therapeutic potential of psilocybin on the upswing, ... Full story available on Benzinga.com psilocybin depression fungus nasdaq research

Read More